Genesis Healthcare Inc. (NYSE:GEN) went down by -7.56% from its latest closing price compared to the recent 1-year high of $1.86. The company’s stock price has collected -18.23% of loss in the last five trading sessions. Press Release reported on 02/04/21 that The Law Offices of Frank R. Cruz Announces Investigation of Genesis Healthcare, Inc. (GEN) on Behalf of Investors
Is It Worth Investing in Genesis Healthcare Inc. (NYSE :GEN) Right Now?
Plus, the 36-month beta value for GEN is at 1.48. Opinions of the stock are interesting as 0 analysts out of 2 who provided ratings for Genesis Healthcare Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 1 rated it as “hold,” and 1 as “sell.”
The average price from analysts is $0.54. GEN currently public float of 63.80M and currently shorts hold a 1.84% ratio of that float. Today, the average trading volume of GEN was 3.40M shares.
GEN’s Market Performance
GEN stocks went down by -18.23% for the week, with a monthly jump of 15.42% and a quarterly performance of 66.58%, while its annual performance rate touched -53.74%. The volatility ratio for the week stands at 13.33% while the volatility levels for the past 30 days are set at 12.15% for Genesis Healthcare Inc.. The simple moving average for the period of the last 20 days is -9.64% for GEN stocks with a simple moving average of 17.45% for the last 200 days.
Analysts’ Opinion of GEN
RBC Capital Mkts, on the other hand, stated in their research note that they expect to see GEN reach a price target of $3.50, previously predicting the price at $3. The rating they have provided for GEN stocks is “Sector Perform” according to the report published on November 21st, 2016.
RBC Capital Mkts gave a rating of “Outperform” to GEN, setting the target price at $3 in the report published on May 16th of the previous year.
GEN Trading at 11.47% from the 50-Day Moving Average
After a stumble in the market that brought GEN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -57.21% of loss for the given period.
Volatility was left at 12.15%, however, over the last 30 days, the volatility rate increased by 13.33%, as shares surge +22.40% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +40.10% upper at present.
During the last 5 trading sessions, GEN fell by -18.23%, which changed the moving average for the period of 200-days by +13.33% in comparison to the 20-day moving average, which settled at $0.8878. In addition, Genesis Healthcare Inc. saw 64.14% in overturn over a single year, with a tendency to cut further gains.
Reports are indicating that there were more than several insider trading activities at GEN starting from Reifsnyder JoAnne Susan, who sale 5,313 shares at the price of $0.96 back on Jun 03. After this action, Reifsnyder JoAnne Susan now owns 651,486 shares of Genesis Healthcare Inc., valued at $5,074 using the latest closing price.
Young Stephen Scott, the SVP and Treasurer of Genesis Healthcare Inc., sale 3,315 shares at $0.96 during a trade that took place back on Jun 03, which means that Young Stephen Scott is holding 415,226 shares at $3,166 based on the most recent closing price.
Stock Fundamentals for GEN
Current profitability levels for the company are sitting at:
- +1.12 for the present operating margin
- +4.29 for the gross margin
The net margin for Genesis Healthcare Inc. stands at +0.32. The total capital return value is set at 1.64, while invested capital returns managed to touch 0.43. Equity return is now at value 8.20, with -1.40 for asset returns.
When we switch over and look at the enterprise to sales, we see a ratio of 0.95, with the company’s debt to enterprise value settled at 1.04. The receivables turnover for the company is 7.67 and the total asset turnover is 0.95. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.77.